ערך בספרים למניה: 23andMe Inc. (ME)

23andMe Holding Co. (ME) is overcoming a crisis of confidence and security challenges as it seeks to monetize the largest array of genomic data and CircleDNA test sales. The book value per common share reflects capital dynamics, where the value of 2.37 serves as the current metric. Meanwhile, 23andMe Holding Co. (ME) delegates cloud computing, logistics, and laboratory processing of biomaterials to external IT contractors and service partners.

For 23andMe Holding Co. (ME), tangible laboratory assets are augmented by the value of the genome database, which is reflected in the trend of the book value per share. This indicator captures the difference between all of the issuer's assets and liabilities, determining the physical cost basis of a single share to assess the market discount and analyze business stagnation risks.